Search Results

Move Reinforces NantHealth’s Commitment to Improved Connectivity For Payers, Providers, and Revenue Cycle Organizations

NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, reported financial results for its second quarter ended June 30, 2020.

NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced the acquisition of The OpenNMS Group, Inc., the world’s premier open-source network management company, which will operate as a subsidiary of NantHealth.

NantHealth Presented These Findings at the ASCO 2020 Gastrointestinal Cancers Symposium

NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, reported financial results for its first quarter ended March 31, 2020.

Masimo will acquire the Connected Care assets from NantHealth, Inc. for a $47.25 million upfront cash payment.

NantHealth Announces Eviti Product Updates to Aid Efficiency and Reporting for Payers & NaviNet Product Updates to Enhance the User Experience

NantHealth and ImmunityBio Announce RNA Profiling for Clinical Decision Support Publication In Nature’s Scientific Reports Study demonstrates the viability and value of RNA sequencing from formalin fixed samples in gaining a deeper understanding of patient disease biology and in delivering diagnostic, prognostic, and therapeutic value in a clinical setting

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2020 second quarter on Thursday, August 6, 2020, after market close.

NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced its new customer, Wexford Health Sources, Inc.